Mydrat-J Eye Drop is a pharmaceutical solution containing Atropine sulfate (0.01% w/v). Indicated for the treatment of various ophthalmic conditions, such as miosis during cataract surgery, uveitis, and anticholinergic mydriasis. The Atropine-based formula serves to dilate the pupil, reduce intraocular pressure, and alleviate pain associated with certain ocular inflammatory disorders. It is essential to follow the prescribed dosage and administration guidelines to ensure safe and effective use. Use caution when administering to children, the elderly, or those with a history of cardiovascular disease, as atropine may have systemic effects. Always consult a healthcare provider for appropriate use and potential drug interactions.